| Followers | 177 |
| Posts | 11263 |
| Boards Moderated | 0 |
| Alias Born | 04/04/2011 |
Tuesday, October 21, 2014 12:46:03 PM
NRTI +27% Behind Big News & #7 on Breakout Boards!
It is very clear that NRTI will be coming out with their new CBD line early next year with all the top MJ experts in their corner, supporting and endorsing their line of CBD products! That alone is mindblowing, but when you consider the fact that they will own this space due to the fact that they are light years ahead of any competition in the CBD space, you have a phenomenal opportunity to make some great gains imho!
Their CBD line will be of the highest quality and supported by years of research, something the competition can't come close to at the present time. They will be first to market in a unique space that is fore-casted to be the fastest growing segment for the next 5 years. The growth potential is limitless at this point, as there is nothing else in this CBD space that can come remotely close to what they will have on the market.
Let's also not forget about the great infrastructure they have in place to take this to retail very quickly. There is just way too much in their corner for this to be trading at these insane low prices. Look at the chart at the bottom of this message - THIS IS A GREAT ENTRY LEVEL! Cheers!
Today's NEWS:
Inergetics' Scientific/Medical Advisory Board to Meet as Company Enters Final Development Phase of New CBD Product Line
Board to Offer Final Review of Product Formulation Prior to Manufacturing and Launch in Medical Marijuana Dispensaries
PR Newswire Inergetics, Inc.
NEWARK, N.J., Oct. 21, 2014 /PRNewswire/ -- Inergetics, Inc. (NRTI), a world-class developer of nutritional supplements, today announced that it will convene a meeting of its Scientific/Medical Advisory Board on November 20, 2014 in San Francisco/Oakland, California. The advisory board is responsible for guiding the formulation of the proprietary line of natural Cannabidiol (CBD)-based nutritional supplements that Inergetics is planning to bring to market next year.
The meeting is being convened by Inergetics' Chief Science Officer, Carl Germano, RD, CNS, CDN, and will feature the five members of the advisory board: Dr. Justin Fischedick, Dr. Joseph McSherry, Dr. Michelle Sexton, Dr. Yu Shao and Dr. Mark Wallace. Additional participants will include Inergetics CEO Mike James and CMO Jim Kras.
"As we enter the third and final phase of product development for our CBD line of nutritional supplements, we wanted to convene our Scientific/Medical Advisory Board for its final review of and recommendation on the product formulation prior to our beginning the manufacturing process," said Carl Germano. "I look forward to a productive meeting as we continue to mark significant progress toward the market launch of our initial phytocannabinoid product in 2015."
During the meeting in California, the Inergetics team will be touring dispensaries and an extraction facility, as well as reviewing the branding, packaging and marketing of the product line. Inergetics previously announced that the initial product in the line will incorporate an important cannabinoid from a novel non-cannabis source. The company expects that the inaugural product's unique combination of cannabinoids will enable it to deliver additional synergistic benefits in terms of overall efficacy and absorption.
"We are very excited to be entering the final stages of product development for our CBD line of nutritional supplements, beginning with our 'first to market' combination cannabinoid product," said Mike James, CEO of Inergetics. "We are confident that our proven expertise in creating, branding and marketing supplements will translate perfectly to our innovative CBD line of products, and that these products will appeal to consumers experiencing various pain-related ailments," James added.
Inergetics will be launching its new CBD product line in medical marijuana dispensaries in 2015.
Continued updates on the CBD product initiative and the Scientific/Medical Advisory Board will be made available at http://www.inergetics.com/cbd-initiative/.
Inergetics Media Contact
KARV Communications
Jonathan Leibowitz
(212) 333-0273
Inergetics@KARVCommunications.com
http://finance.yahoo.com/news/inergetics-scientific-medical-advisory-board-130000600.html
It is very clear that NRTI will be coming out with their new CBD line early next year with all the top MJ experts in their corner, supporting and endorsing their line of CBD products! That alone is mindblowing, but when you consider the fact that they will own this space due to the fact that they are light years ahead of any competition in the CBD space, you have a phenomenal opportunity to make some great gains imho!
Their CBD line will be of the highest quality and supported by years of research, something the competition can't come close to at the present time. They will be first to market in a unique space that is fore-casted to be the fastest growing segment for the next 5 years. The growth potential is limitless at this point, as there is nothing else in this CBD space that can come remotely close to what they will have on the market.
Let's also not forget about the great infrastructure they have in place to take this to retail very quickly. There is just way too much in their corner for this to be trading at these insane low prices. Look at the chart at the bottom of this message - THIS IS A GREAT ENTRY LEVEL! Cheers!
Today's NEWS:
Inergetics' Scientific/Medical Advisory Board to Meet as Company Enters Final Development Phase of New CBD Product Line
Board to Offer Final Review of Product Formulation Prior to Manufacturing and Launch in Medical Marijuana Dispensaries
PR Newswire Inergetics, Inc.
NEWARK, N.J., Oct. 21, 2014 /PRNewswire/ -- Inergetics, Inc. (NRTI), a world-class developer of nutritional supplements, today announced that it will convene a meeting of its Scientific/Medical Advisory Board on November 20, 2014 in San Francisco/Oakland, California. The advisory board is responsible for guiding the formulation of the proprietary line of natural Cannabidiol (CBD)-based nutritional supplements that Inergetics is planning to bring to market next year.
The meeting is being convened by Inergetics' Chief Science Officer, Carl Germano, RD, CNS, CDN, and will feature the five members of the advisory board: Dr. Justin Fischedick, Dr. Joseph McSherry, Dr. Michelle Sexton, Dr. Yu Shao and Dr. Mark Wallace. Additional participants will include Inergetics CEO Mike James and CMO Jim Kras.
"As we enter the third and final phase of product development for our CBD line of nutritional supplements, we wanted to convene our Scientific/Medical Advisory Board for its final review of and recommendation on the product formulation prior to our beginning the manufacturing process," said Carl Germano. "I look forward to a productive meeting as we continue to mark significant progress toward the market launch of our initial phytocannabinoid product in 2015."
During the meeting in California, the Inergetics team will be touring dispensaries and an extraction facility, as well as reviewing the branding, packaging and marketing of the product line. Inergetics previously announced that the initial product in the line will incorporate an important cannabinoid from a novel non-cannabis source. The company expects that the inaugural product's unique combination of cannabinoids will enable it to deliver additional synergistic benefits in terms of overall efficacy and absorption.
"We are very excited to be entering the final stages of product development for our CBD line of nutritional supplements, beginning with our 'first to market' combination cannabinoid product," said Mike James, CEO of Inergetics. "We are confident that our proven expertise in creating, branding and marketing supplements will translate perfectly to our innovative CBD line of products, and that these products will appeal to consumers experiencing various pain-related ailments," James added.
Inergetics will be launching its new CBD product line in medical marijuana dispensaries in 2015.
Continued updates on the CBD product initiative and the Scientific/Medical Advisory Board will be made available at http://www.inergetics.com/cbd-initiative/.
Inergetics Media Contact
KARV Communications
Jonathan Leibowitz
(212) 333-0273
Inergetics@KARVCommunications.com
http://finance.yahoo.com/news/inergetics-scientific-medical-advisory-board-130000600.html
.PNG)
Join the InvestorsHub Community
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
